| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/23/2003 | EP1328647A1 Isomaltulose synthase |
| 07/23/2003 | EP1328646A2 Regulation of human adenylate cyclase, type iv |
| 07/23/2003 | EP1328645A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 07/23/2003 | EP1328641A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 07/23/2003 | EP1328634A2 Genes expressed in the cell cycle |
| 07/23/2003 | EP1328631A2 Her-2/neu fusion proteins |
| 07/23/2003 | EP1328630A2 Secreted proteins |
| 07/23/2003 | EP1328629A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 07/23/2003 | EP1328625A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328622A2 Protein c or activated protein c-like molecules |
| 07/23/2003 | EP1328620A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells |
| 07/23/2003 | EP1328619A1 Human tuberoinfundibular peptide of 39 residues |
| 07/23/2003 | EP1328550A2 Methods of selecting compounds for modulation of bladder function |
| 07/23/2003 | EP1328545A1 Human gene critical to fertility |
| 07/23/2003 | EP1328537A1 Antisense modulation of bh3 interacting domain death agonist expression |
| 07/23/2003 | EP1328295A2 New interferon beta-like molecules |
| 07/23/2003 | EP1328293A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 07/23/2003 | EP1328291A2 Viruses targeted to hypoxic cells and tissues |
| 07/23/2003 | EP1328287A1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2003 | EP1328151A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 07/23/2003 | EP1029040B1 Method of increasing efficiency of directed evolution of a gene using phagemid |
| 07/23/2003 | EP1007682A4 Novel nucleic acid molecules and uses therefor |
| 07/23/2003 | EP0888540B1 Method of identifying mhc-class i restricted antigens endogenously processed by a cellular secretory pathway |
| 07/23/2003 | EP0814827B1 Vascular endothelial growth factor-b |
| 07/23/2003 | EP0602113B1 Callus-specific promoters |
| 07/23/2003 | EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2 |
| 07/23/2003 | CN1432067A Sperm-DNA complexes for genetically modifying non-human animals |
| 07/23/2003 | CN1432065A Bacterial insecticidal proteins |
| 07/23/2003 | CN1432063A Humanised antibodies to epidermal growth factor receptor |
| 07/23/2003 | CN1432058A Redeposition or backstain inhibition during stonewashing process |
| 07/23/2003 | CN1431300A Method for producing transgene paddy with amount of spikelet being increased |
| 07/23/2003 | CN1431299A Serum-free medium of human epidermis cell and its cultivating method and application |
| 07/23/2003 | CN1431298A Antineoplastic immunocompetent cell-cell of DCIC, its preparing method and applications |
| 07/23/2003 | CN1431297A Serum-free medium and concentrated solution as well as its preparing method |
| 07/23/2003 | CN1115414C Virus carrier used for gene therapy |
| 07/23/2003 | CN1115412C Pro-Urokinase mutants |
| 07/22/2003 | US6596930 Modification of cereal grain hardness via expression of puroindoline protein |
| 07/22/2003 | US6596929 Regulatory sequences for use in generation of disease and damage resistant plants |
| 07/22/2003 | US6596928 Plants synthesizing a modified starch, the generation of the plants, their use, and the modified starch |
| 07/22/2003 | US6596927 Genes coding for flavone synthases |
| 07/22/2003 | US6596925 Compositions and methods for the modification of gene expression |
| 07/22/2003 | US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 07/22/2003 | US6596847 Tissue factor protein variants |
| 07/22/2003 | US6596698 Localized arterial transduction of RB2/pl30 via a viral vector at the time of angioplasty drastically reduces neointimal hyperplasia and prevents restenosis |
| 07/22/2003 | US6596694 Caloporoside derivatives, methods of their preparation and use |
| 07/22/2003 | US6596541 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin |
| 07/22/2003 | US6596540 Method for introduction of an exogenous genetic substance or a physiologically active compound |
| 07/22/2003 | US6596538 Expression vector coding enzymatic polypeptide for use in the preparation of cosmetics, detergents, plastics and lubricants |
| 07/22/2003 | US6596536 Monoclonal antibody for use in the treatment and diagnosis of autoimmune and arthritic diseases |
| 07/22/2003 | US6596535 Adeno-associated viral vector for use as tool in the transfer of genetic information for use in the treatment of arthritis |
| 07/22/2003 | US6596533 Polypeptide for use in the treatment of infections and cell proliferative disorders |
| 07/22/2003 | US6596531 Two stage method for thawing cryopreserved cells |
| 07/22/2003 | US6596527 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of liver disorders |
| 07/22/2003 | US6596526 Furin polypeptides with improved characteristics |
| 07/22/2003 | US6596525 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 07/22/2003 | US6596514 Nucleotide sequences which can improve expression of recombinant proteins two- to eight-fold in stable cell pools when present in an expression vector |
| 07/22/2003 | US6596508 Plasmid for use in te expressing of heterologous proteins |
| 07/22/2003 | US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
| 07/22/2003 | US6596482 Nucleic acids encoding BAZ1α transcriptional regulator and methods of use |
| 07/22/2003 | US6596473 Detection of antiapotosis protein; obtain genetically engineered cells, measure viable cells, incubate with antiapoptosis agent, compare with control, evaluate adjustment in apoptosis activity |
| 07/22/2003 | US6596472 Reproductive cultures containing colloidal silver |
| 07/22/2003 | US6596471 Method of cross-linking tissue with a bis-maleimide compound |
| 07/22/2003 | US6596275 Increasing release of PGE-2, IL-10 and/or IL-4; decreasing expression and secretion of IL-1, IL-12 and/or IFM gamma cytokines; decreasing prescence of CD80, CD86 and/or CD40 antigens; having polylysine-cDNA encoding cell nucleus |
| 07/22/2003 | US6596274 Dermal substitute in cutaneous lesions; repairing damaged connective tissue |
| 07/22/2003 | US6596180 System and method for the production of autologous platelet gel |
| 07/22/2003 | US6596179 Apparatus for the separation of biologic components from heterogeneous cell populations |
| 07/22/2003 | CA2329473C Dna encoding prostaglandin receptor ep1 |
| 07/18/2003 | CA2369985A1 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
| 07/17/2003 | WO2003058248A2 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | WO2003058197A2 Detection of molecular interactions by beta-lactamase reporter fragment complementation |
| 07/17/2003 | WO2003058192A2 System and method for differentiating between cells with normal and pathologically altered cytoskeleton |
| 07/17/2003 | WO2003057926A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/17/2003 | WO2003057907A1 Expression and purification of atm protein using vaccinia virus |
| 07/17/2003 | WO2003057906A1 A new vector for genetically modifying non-human animals |
| 07/17/2003 | WO2003057898A2 Methods and materials for modulating p2x2 |
| 07/17/2003 | WO2003057879A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferase and nucleic acid encoding the same |
| 07/17/2003 | WO2003057878A1 INDUCTION OF THE FORMATION OF INSULIN-PRODUCING CELLS VIA GENE TRANSFER OF PANCREATIC β-CELL-ASSOCIATED TRANSCRIPTIONAL FACTOR |
| 07/17/2003 | WO2003057868A1 Novel n-acetylglucosamines transferase and nucleic acids encoding the same |
| 07/17/2003 | WO2003057866A1 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 07/17/2003 | WO2003057865A1 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements |
| 07/17/2003 | WO2003057864A1 Transgenic papp-a non-human mammals |
| 07/17/2003 | WO2003057862A2 Transdifferentiation of pancreatic acinar cells |
| 07/17/2003 | WO2003057859A2 Genes for altering mitochondrial function and for hybrid seed production |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057854A2 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | WO2003057853A2 Oxidative stress-resistant cell lines and methods of use thereof |
| 07/17/2003 | WO2003057836A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 07/17/2003 | WO2003057835A2 Pak5-related compositions and methods |
| 07/17/2003 | WO2003057833A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 07/17/2003 | WO2003057830A2 Compositions and methods for hydroxylating epothilones |
| 07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | WO2003057826A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 07/17/2003 | WO2003057823A2 Epitope synchronization in antigen presenting cells |
| 07/17/2003 | WO2003057820A2 Peptide activators of vegf |
| 07/17/2003 | WO2003057729A2 Mammal prolactin variants |
| 07/17/2003 | WO2003057726A1 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057719A2 Methods of modulating localization and physiological function of ip3 receptors |